These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16763826)

  • 1. Prediction of total propofol clearance based on enzyme activities in microsomes from human kidney and liver.
    Al-Jahdari WS; Yamamoto K; Hiraoka H; Nakamura K; Goto F; Horiuchi R
    Eur J Clin Pharmacol; 2006 Jul; 62(7):527-33. PubMed ID: 16763826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
    Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
    Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Glucuronidation of the antiepileptic drug retigabine: results from studies with human volunteers, heterologously expressed human UGTs, human liver, kidney, and liver microsomal membranes of Crigler-Najjar type II.
    Borlak J; Gasparic A; Locher M; Schupke H; Hermann R
    Metabolism; 2006 Jun; 55(6):711-21. PubMed ID: 16713428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of in vitro glucuronidation clearance of a range of drugs in human kidney microsomes: comparison with liver and intestinal glucuronidation and impact of albumin.
    Gill KL; Houston JB; Galetin A
    Drug Metab Dispos; 2012 Apr; 40(4):825-35. PubMed ID: 22275465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for significant differences in microsomal drug glucuronidation by canine and human liver and kidney.
    Soars MG; Riley RJ; Findlay KA; Coffey MJ; Burchell B
    Drug Metab Dispos; 2001 Feb; 29(2):121-6. PubMed ID: 11159800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance.
    Soars MG; Burchell B; Riley RJ
    J Pharmacol Exp Ther; 2002 Apr; 301(1):382-90. PubMed ID: 11907196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro glucuronidation of propofol in microsomal fractions from human liver, intestine and kidney: tissue distribution and physiological role of UGT1A9.
    Mukai M; Tanaka S; Yamamoto K; Murata M; Okada K; Isobe T; Shigeyama M; Hichiya H; Hanioka N
    Pharmazie; 2014 Nov; 69(11):829-32. PubMed ID: 25985579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raloxifene glucuronidation in human intestine, kidney, and liver microsomes and in human liver microsomes genotyped for the UGT1A1*28 polymorphism.
    Trdan Lusin T; Trontelj J; Mrhar A
    Drug Metab Dispos; 2011 Dec; 39(12):2347-54. PubMed ID: 21937736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propofol inhibits renal cytochrome P450 activity and enflurane defluorination in vitro in hamsters.
    Chen TL; Chen TG; Tai YT; Chang HC; Chen RM; Lin CJ; Ueng TH
    Can J Anaesth; 2000 Jul; 47(7):680-6. PubMed ID: 10930209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species and sex differences in propofol glucuronidation in liver microsomes of humans, monkeys, rats and mice.
    Mukai M; Isobe T; Okada K; Murata M; Shigeyama M; Hanioka N
    Pharmazie; 2015 Jul; 70(7):466-70. PubMed ID: 26373207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scaling factors for the in vitro-in vivo extrapolation (IV-IVE) of renal drug and xenobiotic glucuronidation clearance.
    Knights KM; Spencer SM; Fallon JK; Chau N; Smith PC; Miners JO
    Br J Clin Pharmacol; 2016 Jun; 81(6):1153-64. PubMed ID: 26808419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human hepatic metabolism of a novel 2-carboxyindole glycine antagonist for stroke: in vitro-in vivo correlations.
    Gilissen RA; Ferrari L; Barnaby RJ; Kajbaf M
    Xenobiotica; 2000 Sep; 30(9):843-56. PubMed ID: 11055263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a physiologically based pharmacokinetic model to assess propofol hepatic and renal glucuronidation in isolation: utility of in vitro and in vivo data.
    Gill KL; Gertz M; Houston JB; Galetin A
    Drug Metab Dispos; 2013 Apr; 41(4):744-53. PubMed ID: 23303442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of propofol analogs on glucuronidation of propofol, an anesthetic drug, by human liver microsomes.
    Shimizu M; Matsumoto Y; Yamazaki H
    Drug Metab Lett; 2007 Jan; 1(1):77-9. PubMed ID: 19356023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic and intestinal glucuronidation of mono(2-ethylhexyl) phthalate, an active metabolite of di(2-ethylhexyl) phthalate, in humans, dogs, rats, and mice: an in vitro analysis using microsomal fractions.
    Hanioka N; Isobe T; Kinashi Y; Tanaka-Kagawa T; Jinno H
    Arch Toxicol; 2016 Jul; 90(7):1651-7. PubMed ID: 26514348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.
    Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T
    Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premedication medicines do not cause drug metabolic interaction with propofol using human liver microsomes in vitro.
    Tanaka E; Takano Y; Inomata S; Toyooka H; Honda K
    Eur J Clin Pharmacol; 2004 Oct; 60(8):565-8. PubMed ID: 15351923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro glucuronidation kinetics of deoxynivalenol by human and animal microsomes and recombinant human UGT enzymes.
    Maul R; Warth B; Schebb NH; Krska R; Koch M; Sulyok M
    Arch Toxicol; 2015 Jun; 89(6):949-60. PubMed ID: 24927789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of UDP-glucuronosyltransferase isoforms responsible for leonurine glucuronidation in human liver and intestinal microsomes.
    Tan B; Cai W; Zhang J; Zhou N; Ma G; Yang P; Zhu Q; Zhu Y
    Xenobiotica; 2014 Sep; 44(9):775-84. PubMed ID: 24635759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species-associated differences in the inhibition of propofol glucuronidation by magnolol.
    Yang L; Zhu L; Ge G; Xiao L; Wu Y; Liang S; Cao Y; Yang L; Wang D
    J Am Assoc Lab Anim Sci; 2014 Jul; 53(4):408-11. PubMed ID: 25199099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.